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Illicit drug use results in considerable social and economic costs to Australia (Collins & 
Lapsley 2008) but the magnitude of use is inherently difficult to measure. Besides being 
a clandestine behaviour, drug use in the community is not static and can peak at certain 
events (such as music festivals; Hesse, Tutenges & Schliewe 2010) or celebratory times of 
the year (such as New Year Eve; van Nuijs et al. 2011). Drug trends are triangulated across 
monitoring systems that employ different research methods and a mix of strengths with 
respect to, among other things, timeliness, reliability, drug-specificity and sample size (see 
Griffith & Mounteney 2010).
Metrics regarding the illicit drug market are relevant to the Australian Government’s National 
Drug Strategy 2010–2015 (MCDS 2011). The quantity of drugs consumed by users 
reflects the total Australian supply minus that intercepted by law enforcement agencies at 
borders and within the country. It is possible that drug consumption may increase despite 
increased interception if the total Australian supply increases by a greater amount and 
the market takes advantage of the net increase in supply. Quantitative law enforcement 
seizure data are readily obtained from publications such as those provided by the Australian 
Crime Commission (ACC 2011). A range of monitoring instruments (a number of which 
are described in this article) are also able to indicate long term trends and preferences in 
consumption; however, measures of the total quantity of drugs consumed in a community 
are as yet unavailable. This article describes a way of collecting these consumption data.
A key monitoring system in Australia is the National Drug Strategy Household Survey 
(NDSHS), which interviews over 25,000 participants (aged 14 years or older) and is 
conducted every three years (AIHW 2011). The NDSHS is Australia’s leading indicator of 
the prevalence of illicit drug use in the community. Although the NDSHS is expensive and 
possibly underestimates the true use by the general population of illicit drugs, such as 
heroin and cocaine, it nevertheless provides a valuable indication of the relative prevalence 
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Foreword | Estimating the use of illicit 
drugs in the general community is an 
important task with ramifications for law 
enforcement agencies, as well as health 
portfolios. Australia has four ongoing 
drug monitoring systems, including the 
AIC’s DUMA program, the National Drug 
Strategy Household Survey, the Illicit 
Drug Reporting System and the Ecstasy 
and Related Drug Reporting System. The 
systems vary in methods, but broadly 
they are reliant upon self-report data and 
may be subject to selection biases. The 
present study employed a completely 
different method. By chemically 
analysing sewerage water, the study 
produced daily estimates of consumption 
of methamphetamine, MDMA and 
cocaine. Samples were collected in 
November 2009 and November 2010 
from a municipality in Queensland, with 
an population of over 150,000 people. 
Estimates were made of the average 
daily dose and average daily street  
value per 1,000 people. On the basis  
of estimated dose and price, the 
methamphetamine market appeared 
considerably stronger than either MDMA 
or cocaine. This paper explains the 
strengths and weaknesses of wastewater 
analysis. It considers the potential value 
of wastewater analysis in measuring net 
consumption of illicit drugs and the 
effectiveness of law enforcement agency 
strategies.
Adam Tomison 
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of the use of different drugs as well as binge 
drinking (Hall & Degenhardt 2009).
The Illicit Drug Reporting System (IDRS) 
collates information from a variety of 
sources, including drug-related arrest 
and seizure data, hospital data and 
interviews with injecting drug users, as 
well as key experts from health and law 
enforcement agencies (Stafford & Burns 
2011). Comparatively inexpensive, the 
particular strength of the IDRS has been 
to monitor national trends in the use of 
injectable illicit drugs, including heroin, 
cocaine and methamphetamine (Hall 
& Degenhardt 2009). The Ecstasy and 
Related Drug Reporting System (EDRS) 
augments the IDRS by interviewing 
frequent consumers of ecstasy 
(3,4-methylenedioxymethamphetamine, 
MDMA), who provide richer data regarding 
substances sometimes classified as ‘club 
drugs’ such as MDMA and GHB (gamma-
hydroxybutyric acid; Black et al. 2008). 
Finally, the Drug Use Monitoring in Australia 
(DUMA) program monitors drug use by 
arrestees through quarterly urinalysis and 
survey data in six Australian jurisdictions 
(Gaffney et al. 2010). DUMA plays a critical 
role in monitoring harms that impact the 
community through the drug-crime nexus.
Due to its focus on the general population, 
NDSHS necessarily reports lower rates of 
drug use compared with IDRS, EDRS and 
DUMA. The systems also differ regarding 
the relative prevalence or ‘ranking’ of the 
major drug types as presented in Table 
1, reflecting the particular focus of the 
sampling in each study.
Table 1 shows the predominance of 
cannabis. Methamphetamine use appears 
relatively high among the special cohorts, 
but lower than MDMA in NDSHS. Cocaine 
use is ranked second last or last across all 
monitoring systems. It is possible that this 
represents an underestimation of the true 
extent of cocaine use in the community. 
Urinalysis may under-represent cocaine use 
because of the rate at which it is excreted 
by the body; the DUMA authors suggest 
that the self-reported rate of cocaine use of 
three to four percent may be a more reliable 
estimate (Gaffney et al. 2010; see further 
Melis, Castiglioni & Zuccato 2011). More 
generally, Dunn et al. (2011) have suggested 
that, while current monitoring systems 
reach both lower-middle, socioeconomic 
recreational polydrug users (young, club 
drug users) and those who inject cocaine, 
they do not reach a third important group, 
namely those cocaine users who occupy 
the higher end of the socioeconomic scale. 
As well as apparently being reluctant to 
participate in surveys, this group is not well 
represented in police detainee samples and 
is unlikely to present to public treatment 
services where cocaine-related harm might 
be recorded.
National data relating to the number and 
size (weight) of illicit drug seizures provide 
important indicators of market activity. 
However, drug seizure and arrest data are 
influenced by the activities and policies 
of drug law enforcement agencies; for 
example, an increase in resources directed 
at drug seizures will result in an increase 
in drug seizures (Willis, Anderson & Homel 
2011). Data on seizures are also difficult 
to interpret from a law enforcement 
perspective. For example, a low seizure rate 
may indicate success because it reflects 
reduced drug market activity, or it may 
indicate failure because agencies have  
not been able to detect drug trafficking.
Between 2001–02 and 2008–09, in terms 
of both number and weight of seizures, 
the most prevalent drugs were cannabis 
(Δ9-tetrahydrocannibinol, THC), then 
amphetamine-type substances (ATS), 
other and unknown drugs, heroin and 
other opioids, and lastly cocaine (ACC 
2010). Unfortunately, seizure data do not 
differentiate between methamphetamine 
and MDMA, which are both included in  
the ATS category. Anecdotal evidence from 
Australian forensic laboratories indicates 
that methamphetamine is far more prevalent 
than MDMA (Quinn 2009).
Wastewater analysis
Chemists can now quantify a wide variety 
of substances in wastewater (ie sewage) 
including those associated with illicit drug 
consumption (van Nuijs et al. 2010). The 
method has been used to measure drug 
use in Europe, North America and Australia 
(Irvine et al. 2011; Lai et al. 2011) and to 
compare drug use across different cities 
and time periods (Zuccato et al. 2011). 
This paper demonstrates how recent 
advances in analytical chemistry can assist 
with measuring drug use in the Australian 
community.
Unlike the drug monitoring systems 
outlined above that provide person-
centric data, wastewater analysis (WWA) 
is population-based and cannot provide 
person level information on individuals’ drug 
consumption, including frequency of use or 
polydrug use.
However, WWA can efficiently provide 
reliable, objective chemical data on the 
use of methamphetamine, MDMA and 
cocaine—drugs of major concern to the 
community—in both small and very large 
population groups (potentially hundreds of 
thousands of people). The analyses may 
also be conducted at a high frequency 
Table 1 Rates of illicit drug use recorded by drug monitoring systems
National Drug 
Strategy Household 
Survey 2010
Illicit Drug 
Reporting System 
2010
Ecstasy & Related 
Drug Reporting 
System 2010
Drug Use 
Monitoring 
Australia 2008
General  
population, 14+
People who 
regularly inject 
drugs
Regular 
consumers  
of MDMA
People detained 
by police
% used last 12 
months (n=26,648)
% used last  
6 months (n=902)
% used last  
6 months (n=693)
% urinalyses 2008 
(n=3,101)
Cannabis 10.3 75 80 48
MDMA 3.0 14 100a 3
Methamphetamineb 2.1 60 56 21
Cocaine 2.1 18 48 1
Heroin 0.2 64 4 11
a: Since MDMA use is required for participation in EDRS studies, its use appears as 100%
b: While DUMA reports on use of ‘amphetamine’ and ‘amphetamine-type substance’ (Gaffney et al. 2010: 14), this is practically equivalent to 
methamphetamine, due to the almost exclusive use of the latter in Australia (ACC 2010)
Note: Regular means injection/use of a drug 6 or more times in the last 6 months
Sources: AIHW (2011); Gaffney et al. (2010); Sindicich and Burns (2011); Stafford and Burns (2011)
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to give, for instance, daily readings. 
This method circumvents the difficulties 
involved in accessing high socioeconomic 
cocaine users. It also avoids one problem 
regarding self-reported substance use that is 
particularly relevant to use of tablets sold as 
MDMA. Deceptive trade practices in the illicit 
drug market mean that methamphetamine 
or other substances are substituted in 
tablets purporting to contain MDMA (Parrott 
2004). Whereas self-report studies reflect 
users’ belief regarding substance use, 
WWA (similar to DUMA) provides objective 
data that accurately differentiates between 
drugs such as methamphetamine and 
MDMA. Finally, WWA data are not subject to 
changes in the activities and policies of drug 
law enforcement agencies in the same ways 
as drug seizure and arrest data.
This paper presents findings from a 
national team (see Lai et al. 2011), who 
sampled a wastewater treatment plant in 
a major municipality of Queensland, with 
a population of over 150,000 people (the 
actual figure from local government records. 
is withheld) The objectives of the research 
were to compare Australian drug monitoring 
systems with wastewater data sampled 
over two time points in 2009 and 2010. For 
the reasons outlined below, the analyses 
excluded cannabis and heroin and instead 
focused on methamphetamine, cocaine  
and MDMA.
What does WWA measure?
When an illicit drug is consumed it passes 
into the bloodstream, exerts its affect upon 
the body and is then excreted in urine, 
faeces, saliva and sweat. The process of 
excretion occurs even when illicit drugs 
are administered via different methods—
injecting, smoking, snorting, swallowing  
and so forth. Most drugs are excreted within 
a few hours with the exception of THC (see 
Baselt 2008).
Among the chemicals excreted is the 
unchanged or ‘parent’ drug. Most drugs 
also undergo metabolism, some form of 
alteration as a result of action by the body’s 
enzymes (usually in the liver). The altered 
products are called metabolites. Like their 
parent drugs, metabolites are also excreted 
in urine, faeces etc. Individuals vary in 
their capacity to metabolise drugs, which 
results in individual differences in the parent 
drug and metabolite content of urine. It 
is nonetheless defensible to use average 
human excretion values for each drug. If 
the population contributing to a wastewater 
sample is large, then one can reasonably 
expect that the population’s metabolic 
performance is less variable than that of  
an individual.
In this and similar studies (Zuccato & 
Castiglioni 2011), the investigative strategy 
is to use chemical analysis to quantify the 
levels of parent drugs and metabolites in 
wastewater samples. These levels and the 
average excretion values are used to back-
calculate the estimated total consumption 
of particular drugs in the population that 
were found in the wastewater. In this 
article, the levels of parent drugs and 
metabolites in the wastewater are referred 
to as the ‘loadings’ of those compounds. 
It is important to recognise that the back-
calculated amounts represent the weight of 
the drugs’ active ingredient that has been 
consumed, not the weight of drug powder 
that has been consumed. This is because 
drugs are usually diluted with varying 
quantities of ‘cutting’ agents, such as sugar 
or glucose. Care must therefore be taken 
when attempting to compare the weights 
of drugs reported here and in other WWA 
studies with street seizure weight data such 
as those reported in IDRS.
Cocaine estimation
The urine of an individual who has 
consumed cocaine will contain cocaine and 
its metabolite, benzoylecgonine (BE) (see 
Baselt 2008). Back-calculations for most 
drugs are subject to some uncertainty as 
indicated in the following sections (Khan & 
Nicell 2011; Lai et al. 2011). However, back-
calculating cocaine involves less uncertainty 
largely due to the fact that neither cocaine 
nor BE are produced by consumption of 
other drugs or environmental sources (Khan 
& Nicell 2011).
Methylamphetamine 
(methamphetamine) estimation
One of the major metabolites of 
methamphetamine is amphetamine. The 
urine of a person who has consumed 
methamphetamine will therefore contain 
both methamphetamine and amphetamine 
(Baselt 2008). Two factors can produce 
unreliability when back-calculating the 
rate of consumption of methamphetamine 
through WWA. First, methamphetamine is 
also a metabolite of selegiline (a drug used 
to treat Parkinson’s disease). Therefore, the 
legal use of selegiline will inflate the apparent 
rate of methamphetamine consumption. 
Fortunately, the known usage of selegiline 
in Australia is small so its contribution to the 
wastewater load of methamphetamine is 
likely to be negligible (Hollingworth, Rush, 
Hall & Eadie 2011; Irvine et al. 2010).
Second, amphetamine in wastewater 
can arise as a result of the legal 
usage of dexamphetamine (a drug 
prescribed primarily to treat attention 
deficit hyperactivity disorder), the illegal 
consumption of amphetamine as well as the 
illegal consumption of methamphetamine. 
Back-calculation of methamphetamine 
consumption from loadings of amphetamine 
will therefore overestimate the consumption 
of methamphetamine. However, in Australia 
amphetamine is rarely found in police 
drug seizures or produced in clandestine 
laboratories (ACC 2011); therefore, this 
source of amphetamine in wastewater can 
be ignored for practical purposes.
In order to maximize the accuracy of 
the back-calculations, this study used 
Queensland prescription data from the 
Pharmaceutical Benefit Scheme (PBS) to 
subtract contributions from both selegiline 
and dexamphetamine usage (Hollingworth 
et al. 2011a, 2011b).
MDMA estimation
Similar uncertainties affect estimates 
of consumption of MDMA. Following 
consumption of MDMA, the user’s 
urine will contain both MDMA 
and metabolites, including MDA 
(3,4-methylenedioxyamphetamine), 
which is itself an illicit drug and also a 
metabolite of MDEA (3,4-methylenedioxy-
N-ethylamphetamine). For these reasons, 
loadings of MDA are not typically used to 
back-calculate use of MDMA.
Heroin estimation
Heroin is metabolised so rapidly that it 
is rarely found in urine. Its metabolite, 
morphine, is usually found. Estimation of 
the rate of consumption of heroin from 
WWA is difficult because morphine in 
wastewater can arise from consumption 
of pharmaceutical morphine and codeine, 
4  |  Australian Institute of Criminology
as well as heroin. Since codeine can be 
purchased without a prescription, total 
codeine consumption figures are not 
available at the level of accuracy required 
to allow back-calculation of heroin 
consumption through WWA.
THC estimation
Although the loading of THC-acid (a 
metabolite of THC, the active ingredient 
in cannabis products) was measured in 
wastewater by the present study, these 
data are not presented here. Laboratory 
tests indicate that the current analytical 
method used in this study and in other 
laboratories substantially under-represents 
the loading of THC-acid and produces 
inaccurate estimates of THC consumption. 
This is because THC-acid tends to bind with 
solids/particulates and so is not available for 
analysis in the water phase (Khan & Nicell 
2011).
Benefits of measuring both parent 
drugs and metabolites
The fact that both parent drug and 
metabolite can be measured in wastewater 
offers opportunities for quality assurance 
in measuring illicit drug consumption in the 
population. For example, with cocaine the 
rate of consumption in a community can be 
estimated from either the measured cocaine 
parent in wastewater or from the measured 
BE value. In this study, good agreement was 
found between the two estimates, thereby 
verifying their reliability. In this Trends & 
Issues paper, for methamphetamine and 
cocaine consumption figures, average 
consumption values calculated from both 
the parent drug and metabolite loadings are 
reported.
Calculating doses from loadings
The loadings within the population 
have been converted to the estimated 
number of doses consumed per capita. 
For this purpose, the assumption has 
been made that a typical dose of illicit 
methamphetamine is between 20mg 
(P Pigou, Forensic Science SA, South 
Australian Attorney-General’s Department, 
personal communication 5 September 
2011) and 41mg—based on median 
consumption amounts reported in survey 
studies from Queensland (Sindicich & Burns 
2011, 2010) and purity of analysed seizures 
from Queensland (ACC 2011, 2010) in the 
same year (see Table 3). It has also been 
assumed that a typical dose of cocaine is 
140–150mg (Sindicich & Burns 2011, 2010; 
ACC 2011, 2010) and MDMA is 60–100mg, 
based on data from Victoria Police Forensic 
Services Department (Quinn 2009).
Population
In order to calculate per capita usage, an 
accurate measure of the population of the 
wastewater catchment is needed. Local 
government statistics on the number of 
residents within a geographical region do 
not take into account the number of visitors 
or absentees. Local government statistics 
on the catchment population in this study 
are withheld. The figure is over 150,000 
people.
Dumping illicit drugs in sewers
Illicit drugs are sometimes flushed down 
sewers to avoid detection by police. 
Wastewater analysis cannot chemically 
distinguish between dumped drugs and 
parent drugs that have been consumed 
and excreted. However, the high value 
of illicit drugs makes it improbable that 
dumping would occur on a large enough 
scale to affect estimates. Additionally, the 
good agreement found in the present study 
between the parent drugs and metabolites 
of both cocaine and methamphetamine  
indicates that dumping is not a significant 
issue. If it were, the metabolite loadings 
would be appreciably lower than the parent 
drug loadings.
Method
Raw wastewater samples were collected at 
the inlet of a sewage treatment plant (STP) 
that receives wastewater from a catchment 
in Queensland with a population of over 
150,000 persons. Two sampling campaigns 
obtained daily composite samples for:
•	 20 November—1 December 2009  
(12 days); and
•	 11—25 November 2010 (15 days).
A continuous flow proportional sampling 
mode was used to collect representative  
24 hour composited wastewater samples 
(Ort et al. 2010). Samples were refrigerated 
at 4oC during collection, preserved using 
2M hydrochloric acid on site, transported 
with ice and stored in darkness at -20oC 
until analysis. Samples were collected at 
6:00 am each day.
Using a validated analytical method (Lai et 
al. 2011), the concentrations of cocaine, 
BE, amphetamine, methamphetamine and 
MDMA were measured in the samples. 
Generally, acidified wastewater samples 
were spiked with isotopically-labelled drugs 
as internal standards. Target chemicals in 
the samples were pre-concentrated by solid 
phase extraction cartridges (mixed cation-
exchange) and then eluted as extracts that 
were analysed by liquid chromatography, 
coupled with tandem mass spectrometry.
The back-calculation method employed in 
the literature (eg Zuccato et al. 2008, 2011) 
was applied. Briefly, daily mass loadings 
(mg/day) of chemicals were estimated by 
multiplying chemical concentrations (ug/L) 
measured in samples with the daily flow rate 
(L/day) of the wastewater. Mass loadings 
were then converted to masses of drugs 
consumed using the excretion fractions  
of the parent drug and/or metabolite. 
After normalisation to the catchment 
population, the figures of per capita chemical 
consumption (mg/day/1,000 people) were 
arrived at. The daily doses consumed per 
capita (doses/day/1,000 people) were back-
estimated using typical dose (mg) values for 
each particular drug.
Non-parametric Kolmogorov-Smirnov tests 
were used to assess changes in estimated 
drug consumption patterns between the 
2009 and 2010 sampling periods. Pearson 
correlation analysis was used to assess 
correlations between concentrations of 
parent drugs and metabolites. The statistical 
analyses were conducted with SPSS and 
SigmaStat software (Version 3.5).
Results
Table 2 presents the estimated milligrams 
per day per 1,000 people for cocaine, 
methamphetamine and MDMA.
Table 2 indicates that the recorded levels 
of all drugs varied daily over the 12 days of 
sampling in 2009 and the 15 days in 2010. 
Increased quantities of methamphetamine, 
cocaine and ecstasy were detected on 
Saturdays and Sundays. As samples 
were collected at 6.00 am each day, this 
likely reflects consumption on Friday and 
Australian Institute of Criminology  |  5
Saturday nights. There were also notable 
changes in the levels of drugs identified 
in the two sampling periods. The average 
loading per 1,000 people of cocaine in  
2009 (221mg, SD=100) was more than  
four times that seen in 2010 (52mg, 
SD=21); a significant decline—Kolmogorov-
Smirnov Z=2.58, p<0.001. Conversely, 
loadings of methamphetamine increased 
between 2009 (158mg, SD=40) and 2010 
(228mg, SD=40)—Kolmogorov-Smirnov 
Z=1.81, p=0.003. No changes were 
apparent in mean MDMA loadings between 
2009 (131mg, SD=62) and 2010 (139mg, 
SD=125)—Kolmogorov-Smirnov Z=0.99, 
p=0.213. Daily loadings are displayed in 
Figure 1, which presents each drug type by 
each sampling year (mg/day/1,000 people).
Table 3 presents the mean of the loadings 
per 1,000 people for the three drug types in 
each year. It also presents estimated doses 
per 1,000 people and the corresponding 
estimated street value.
Table 3 takes into account the fact 
that standard drug doses differ for 
methamphetamine and MDMA. Additionally, 
the estimates of standard drug doses for all 
three substances changed between 2009 
and 2010, as did estimates of the cost of a 
standard dose. The mean number of doses 
per 1,000 people per day was calculated 
by dividing the mean mg/1,000 people—
derived from WWA—by the standard dose 
estimates. Multiplying these figures by the 
cost per dose gives the estimated mean 
street value of each drug per 1,000 people 
per day.
For example, in the 12 days of sampling in 
2009, it was estimated that an average of 
158mg of methamphetamine was used per 
1,000 people. Using the upper estimate 
of 41mg per dose, this translated to an 
average of 3.9 doses per day per 1,000 
people. Multiplying this by $90 indicates 
that over the sampling period an average 
of $347 was spent on methamphetamine 
each day for every 1,000 people in the 
catchment.
Importantly, Table 3 illustrates that after 
standard doses were taken into account, 
the most commonly consumed drug was 
methamphetamine in both years. Even 
on the basis of a 41mg standard dose, 
methamphetamine use during the 2009 
sampling period was higher than MDMA 
and cocaine. In 2010, methamphetamine 
use was 2.9–8.1 times higher than MDMA 
and 22–38 times higher than cocaine.
In terms of estimated daily street value, 
cocaine ($237 per 1,000) was comparable 
to methamphetamine ($347–711 per 1,000) 
in 2009. But in 2010, estimated expenditure 
on methamphetamine was many times 
greater than the other two substances.
Discussion
This study covered a limited geographical 
range, a limited number of drugs and 
collected data at only two points in time—
both of which are celebratory periods 
for many young people when drug use 
might be expected to increase (November 
2009 and 2010). The study provided no 
information on individuals’ patterns of drug 
Table 2 Daily consumption (mg/day/1,000 people^) of illicit drugs in the catchment 
November 2009 and 2010
2009 Cocainea Methamphetamineb MDMA
Friday 20/11 188 207 66
Saturday 21/11 297 183 105
Sunday 22/11 421 240 254
Monday 23/11 203 123 142
Tuesday 24/11 148 145 127
Wednesday 25/11 122 113 91
Thursday 26/11 143 125 84
Friday 27/11 159 117 78
Saturday 28/11 275 155 124
Sunday 29/11 293 168 178
Monday 30/11 196 132 139
Tuesday 1/12 203 189 179
Mean mg 221 158 131
2010 Cocainea Methamphetamineb MDMA
Thursday 11/11 52 204 56
Friday 12/11 54 197 45
Saturday 13/11 79 240 127
Sunday 14/11 80 275 363
Monday 15/11 58 235 208
Tuesday 16/11 34 211 98
Wednesday 17/11 32 194 56
Thursday 18/11 35 199 47
Friday 19/11 44 213 50
Saturday 20/11 68 271 134
Sunday 21/11 79 304 350
Monday 22/11 62 277 252
Tuesday 23/11 43 247 150
Wednesday 24/11 30 176 74
Thursday 25/11 27 178 74
Mean mg 52 228 139
a: Average of back-calculations from cocaine (parent drug) and metabolite (benzoylecgonine)
b: Average of back-calculations from methamphetamine (parent drug) and metabolite (amphetamine)
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use. Nevertheless, the study produced 
interesting findings concerning a very 
large population. The findings were not 
subject to sampling selection biases that 
may arise from low participation rates or 
under-reporting of drug use in surveys. Nor 
were they likely to be affected by drug law 
enforcement agency activity in the same 
way as are drug seizure and arrest data.
The loading data spiked on weekends. 
Since samples were collected at 6:00 am, 
this probably reflects an increase in drug 
consumption on Fridays and Saturdays. 
More important, the load data also indicate 
a statistically significant decline in cocaine 
levels between 2009 and 2010. The reverse 
pattern was found for methamphetamine 
—a statistically significant increase in 
methamphetamine use between 2009 and 
2010. This suggests that these two drugs 
may be economic substitutes for each other. 
The interrelationship could be explored 
further in the Australian context in surveys, 
with geographically defined information on 
price, purity and supply. The current findings 
are broadly similar to Zuccato et al.’s (2011) 
European study inasmuch as they detect 
fluctuations over time, differing between 
drug types.
It is suggested that estimating numbers of 
doses per 1,000 people is valuable, despite 
the uncertainties involved. This is because 
it is only after doses are calculated that 
the scale of the methamphetamine market 
and its full cash value can be estimated. 
The dose data indicate that during the 
two periods of sampling, consumption of 
methamphetamine was greater than either 
MDMA or cocaine, especially in 2010. 
These results are consistent with findings 
from other studies regarding the frequency 
of use. Among NDSHS participants, daily 
or weekly use of methamphetamine was 
reported more commonly than daily or 
weekly use of MDMA or cocaine (AIHW 
2011). The current data are also consistent 
with IDRS and DUMA (see Table 1), which 
both report that methamphetamine use is 
considerably higher than either MDMA or 
cocaine (among injecting drug users and 
arrestees respectively).
The findings regarding the drop in cocaine 
use from 2009–10 differ from other studies. 
The IDRS reported cocaine use to be stable 
across 2008–09 nationally (Stafford & Burns 
2011). A national increase in cocaine use 
was reported in both the EDRS (2009–10) 
(Sindicich & Burns 2011) and the NDSHS 
(2007–10) (AIHW 2011). It is difficult to 
reconcile these findings. Since the data 
concern a particular region of Queensland 
and small time periods—12 days and  
15 days respectively in 2009–10—it may 
be that irregular fluctuations in the cocaine 
market were detected. Arguably, WWA has 
greater capacity to detect such fluctuations 
because of its high temporal resolution; 
WWA in this study involved daily data 
points. By contrast, IDRS asks participants 
to report on the previous six months of  
drug use and for NDSHS, the time frame 
is 12 months. In addition, as noted, WWA 
is not likely to be subject to some of the 
problems associated with reaching certain 
types of cocaine users, unlike NDSHS, 
EDRS and IDRS (Dunn et al. 2011). Finally, 
the sample size was very large (over 
150,000 people) and is several times 
larger than the samples sizes of NDSHS, 
EDRS and IDRS combined. The authors 
concur with the findings of the Crime 
and Misconduct Commission that the 
Queensland cocaine market deserves  
close monitoring (CMC 2010).
This study has demonstrated that WWA has 
potential to usefully supplement information 
gathered by current drug monitoring 
systems. By producing time sensitive, 
chemical data from large populations, 
the WWA method provides detailed but 
anonymous information on the size and 
evolution of drug markets. Future WWA 
studies could contribute to the evidence 
base for the National Drug Strategy 2010–
2015 by sampling over longer time periods 
and comparing findings from catchments 
in different regions within and between 
jurisdictions. This may be the best way 
of assessing the true size of the cocaine 
market and how it is affected by the strategy 
and actions undertaken by operational law 
enforcement. WWA, combined with current 
price data, can be used to estimate the 
amounts of cash that exchange hands in 
the drug market.
In addition to the strategic information WWA 
can provide, it can also be used in a tactical 
sense. As indicated by the data presented 
in this article, drug consumption can be 
monitored temporally (ie on a daily basis) 
and geographically (ie to suburbs serviced 
by a particular wastewater treatment plant). 
This offers criminal justice agencies the 
potential to measure the effectiveness 
Table 3 Drug type by mean mg per 1,000 people, estimated doses per 1,000 people and 
estimated street value per 1,000 people (November 2009 and November 2010)
Drug type
Mean mg/1,000 
people 
estimated from 
WWA
Standard 
drug dose 
mga
Mean doses 
per 1,000 
people per 
day
Cost per 
dose 
Queensland
($AUD)b
Estimated street 
value per 1,000 
people per day 
($AUD)
2009
Methamphetamine 
(low dose)
158 20 7.9 90 711
Methamphetamine 
(high dose)
158 41 3.9 90 347
MDMA (low dose) 131 60 2.2 20 44
MDMA (high dose) 131 100 1.3 20 26
Cocaine 221 140 1.6 150 237
2010
Methamphetamine 
(low dose)
228 20 11.4 100 1,140
Methamphetamine 
(high dose)
228 34 6.7 100 671
MDMA (low dose) 139 60 2.3 25 58
MDMA (high dose) 139 100 1.4 25 35
Cocaine 52 150 0.3 150 52
a:  Methamphetamine standard dose ranges: 20mg (P Pigou, Forensic Science SA, South Australian Attorney-General’s Department, personal 
communication 5 September 2011), 34–41mg (based on median typical dose consumed by EDRS respondents in Queensland (Stafford & 
Burns 2011, 2010) multiplied by mean purity of Queensland police seizures from the same period (ACC 2011, 2010)). The extremes of these 
2 estimates are displayed in the Table. Cocaine standard dose ranges: 140–150mg (as per estimating procedures for methamphetamine). 
MDMA standard dose ranges: 60–100mg (based on typical contents of a typical single tablet from Victoria Police Forensic Services 
analysis—Quinn 2009).
b: EDRS Queensland median prices for typical dosages (Stafford & Burns 2011, 2010)
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of particular supply reduction strategies, 
such as law enforcement operations. For 
instance, using temporally resolved WWA 
data, police could monitor the impacts 
of significant seizures on regional drug 
consumption. If an impact is observed, 
its duration, size and how quickly it 
commenced would highlight supply–chain 
dynamics and indicate the magnitude of the 
gap between supply and demand. Under 
certain circumstances, examination of 
disruption of drug consumption subsequent 
to the arrest of particular individuals or 
groups might shed light on the extent 
and relative contribution of their trafficking 
networks.
In time, as the efficacy of the WWA method 
improves, it may be considered to form a 
fifth arm of the Australian drug monitoring 
system—one which is able to measure 
across multiple urban and regional sites. 
A national longitudinal map based on 
WWA would address gaps in the current 
monitoring systems arising from sample 
size, frequency of data collection and 
reliance on self-report data. Future analysis 
is required to understand how such a 
national WWA monitoring system might 
also assist with a drug law enforcement 
performance measurement framework, as 
proposed by Willis, Anderson and Homel 
(2011). The developers of the framework 
argue for its need on the basis that it would, 
among other things, provide a rigorous 
evidence-base with which:
•	 law enforcement agencies could 
demonstrate and be accountable for the 
impact of their activities;
•	 long-term strategic decision making could 
be undertaken; and
•	 justifications could be formed for 
expending and seeking resources.
In considering the breadth of data sources 
that need to be incorporated into the 
framework (beyond seizure and arrest 
data), Willis, Anderson and Homel (2011:1) 
note that supply and use of illicit drugs 
‘can only be monitored through use of 
indirect indicators linked to observable 
consequences, such as crime, drug-related 
illness, injury and death’. It is suggested that 
WWA should be included as a measure of 
drug consumption, primarily because WWA 
directly reflects observable consumption of 
all users.
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